ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34 | +6.2% | 1,722 | +4.8% | 0.00% | – |
| Q2 2023 | $32 | +23.1% | 1,643 | +2.8% | 0.00% | – |
| Q1 2023 | $26 | +8.3% | 1,598 | +25.0% | 0.00% | – |
| Q4 2022 | $24 | -99.9% | 1,278 | -22.0% | 0.00% | – |
| Q3 2022 | $25,000 | +19.0% | 1,638 | +0.3% | 0.00% | – |
| Q2 2022 | $21,000 | -12.5% | 1,633 | +4.3% | 0.00% | – |
| Q1 2022 | $24,000 | 0.0% | 1,566 | +37.9% | 0.00% | – |
| Q4 2021 | $24,000 | -11.1% | 1,136 | +20.7% | 0.00% | – |
| Q3 2021 | $27,000 | -55.7% | 941 | -33.0% | 0.00% | – |
| Q2 2021 | $61,000 | +2950.0% | 1,404 | +2708.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -99.9% | 50 | -99.9% | 0.00% | -100.0% |
| Q3 2018 | $1,715,000 | – | 69,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |